Login to Your Account



Washington Roundup

Biotech Benefits Appear Safe in Reform Conference Talks

By Donna Young


Monday, December 28, 2009
WASHINGTON - As the health reform legislation faces the difficult compromise road ahead during the upcoming conference process in January, little is expected to change with the measures affecting biotech, including the provisions to create a pathway for approval of follow-on biologics (FOBs). (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription